primary antibody against e2f3 sc-878 (Santa Cruz Biotechnology)
Structured Review

Primary Antibody Against E2f3 Sc 878, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibody against e2f3 sc-878/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3"
Article Title: miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3
Journal: Molecular Medicine Reports
doi: 10.3892/mmr.2016.5901
Figure Legend Snippet: E2F3 was a direct target of miR-34a. (A and B) Schematic representation of WT and mut putative miR-34a-binding sites in the 3′-UTR of E2F3. (C) The 293T cells were transfected with miR-34a mimic and psiCHECK2 containing either the WT or mut putative binding sites for miR-34a, and 48 h later the luciferase assay was performed. The data indicated that miR-34a mimic reduced the Renilla activity in the reporter construct containing the E2F3 site (1.87±0.13), whereas no effect was observed with a construct containing a mut E2F3 seed site (3.46±0.09) and mimic control (3.27±0.04). Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; WT, wild-type; mut, mutant; UTR, untranslated region; NS, non-significant.
Techniques Used: Binding Assay, Transfection, Luciferase, Activity Assay, Construct, Control, Standard Deviation, Mutagenesis
Figure Legend Snippet: miR-34a and siE2F3 reduce E2F3 expression. SRA01/04 cells transfected with miR-34a mimic or siE2F3 exhibited reduced E2F3 expression compared with the mock and mimic control. Data are presented as the mean ± standard deviation; *P<0.05. miR, microRNA; si, small interfering; NS, non-significant.
Techniques Used: Expressing, Transfection, Control, Standard Deviation



